Primary Hyperaldosteronism Secondary to Unilateral Adrenal Hyperplasia: an Unusual Cause of Surgically Correctable Hypertension. A review of 30 cases-Reference-Cited by-同舟云学术

Primary Hyperaldosteronism Secondary to Unilateral Adrenal Hyperplasia: an Unusual Cause of Surgically Correctable Hypertension. A review of 30 cases

Published:2006-12-04 Issue:1 Volume:31 Page:72-79
ISSN:0364-2313
Container-title:World Journal of Surgery
language:en
Short-container-title:World J. Surg.

Author:

Goh Brian K. P.,Tan Yeh-Hong,Chang Kenneth T. E.,Eng Peter H. K.,Yip Sidney K. H.,Cheng Christopher W. S.

Publisher

Springer Science and Business Media LLC

Subject

Surgery

Link

http://link.springer.com/content/pdf/10.1007/s00268-005-0594-8.pdf

Reference30 articles.

1. Conn JW. Primary aldosteronism: a new clinical syndrome. J Lab Clin Med 1955;45:6–17

2. Magill SB, Raff H, Shaker JL, et al. Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. J Clin Endocrinol Metab 2001;86:1066–1071

3. Dluhy RG, Lifton RP. Glucocorticoid-remedial aldosteronism. Endocrinol Metab Clin North Am 1994;23:285–297

4. Farge D, Chatellier G, Pagny JY. Isolated clinical syndrome of primary aldosteronism in four patients with adrenocortical carcinoma. Am J Med 1987;83:635–640

5. Ross EJ. Conn’s syndrome due to adrenal hyperplasia with hypertrophy of zona glomerulosa, relieved by unilateral adrenalectomy. Am J Med 1965;39(6):994–1002

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. [131I]6ß-Iodomethyl-19-norcholesterol SPECT/CT for the Lateralization of Mineralocorticoid Overproduction in Primary Aldosteronism;Diagnostics;2024-09-09

2. Eurasian clinical guidelines for the diagnosis and treatment of secondary (symptomatic) forms of arterial hypertension (2022);Eurasian heart journal;2023-03-01

3. Mineralocorticoid excess;Steroids in the Laboratory and Clinical Practice;2023

4. Hypertension outcomes of adrenalectomy for unilateral primary aldosteronism;Endocrine;2022-02-11

5. Secondary hyperaldosteronism and hypertension;Praxis medica;2021